| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Scott L Friedman | |
| P2860 | cites work | Epithelial-mesenchymal transition and its implications for fibrosis | Q24302042 |
| Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR | Q24551041 | ||
| Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C. | Q50584684 | ||
| A dual reporter gene transgenic mouse demonstrates heterogeneity in hepatic fibrogenic cell populations. | Q50785680 | ||
| Ligands of peroxisome proliferator-activated receptor γ modulate profibrogenic and proinflammatory actions in hepatic stellate cells | Q61763067 | ||
| Apoptosis of T cells in the hepatic fibrotic tissue of the rat: a possible inducing role of hepatic myofibroblast-like cells | Q73175887 | ||
| Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells | Q73322874 | ||
| Is liver fibrosis reversible? | Q73427092 | ||
| History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells | Q28190388 | ||
| Hypoxic stimulation of vascular endothelial growth factor expression in activated rat hepatic stellate cells | Q28378160 | ||
| Foxf1 +/- mice exhibit defective stellate cell activation and abnormal liver regeneration following CCl4 injury | Q28504652 | ||
| Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis | Q28582038 | ||
| Nonalcoholic fatty liver disease | Q29619354 | ||
| Leptin induces increased α2(I) collagen gene expression in cultured rat hepatic stellate cells | Q31139462 | ||
| Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury | Q33822590 | ||
| Chemokines in liver inflammation and fibrosis | Q33960600 | ||
| Matrix as a modulator of hepatic fibrogenesis | Q34391368 | ||
| Cytokine receptors and signaling in hepatic stellate cells | Q34391388 | ||
| Role of malondialdehyde-acetaldehyde adducts in liver injury | Q34528016 | ||
| Transcriptional regulation of hepatic stellate cell activation | Q34637612 | ||
| Redox regulation of cytokine expression in Kupffer cells | Q35019103 | ||
| Hepatic fibrosis: from bench to bedside | Q35020812 | ||
| Vascular mediators in the injured liver | Q35033793 | ||
| Genetic polymorphisms and the progression of liver fibrosis: a critical appraisal | Q35071658 | ||
| Cirrhosis reversal: a duel between dogma and myth | Q35749911 | ||
| Liver fibrosis: from the bench to clinical targets | Q35759110 | ||
| NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis | Q36524368 | ||
| Strain-specific differences in mouse hepatic wound healing are mediated by divergent T helper cytokine responses | Q36591648 | ||
| Leptin receptor-mediated signaling regulates hepatic fibrogenesis and remodeling of extracellular matrix in the rat. | Q38289678 | ||
| Fas enhances fibrogenesis in the bile duct ligated mouse: a link between apoptosis and fibrosis. | Q39632325 | ||
| Proangiogenic role of tumor-activated hepatic stellate cells in experimental melanoma metastasis | Q40668665 | ||
| Liver fibrosis: insights into migration of hepatic stellate cells in response to extracellular matrix and growth factors | Q40679552 | ||
| Up-regulated expression of fractalkine and its receptor CX3CR1 during liver injury in humans. | Q40723449 | ||
| Peroxisome proliferator-activated receptors and hepatic stellate cell activation | Q41758990 | ||
| Vascular endothelial growth factor and receptor interaction is a prerequisite for murine hepatic fibrogenesis | Q41933963 | ||
| Connective tissue growth factor (CTGF/CCN2) in hepatic fibrosis | Q42600836 | ||
| Hepatitis C virus core and nonstructural proteins induce fibrogenic effects in hepatic stellate cells | Q42982855 | ||
| Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition: implications for reversibility of liver fibrosis | Q43858122 | ||
| Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers | Q43878352 | ||
| The chemokine CCL21 modulates lymphocyte recruitment and fibrosis in chronic hepatitis C. | Q43910951 | ||
| Leptin is essential for the hepatic fibrogenic response to chronic liver injury | Q44071052 | ||
| Genome-wide analysis of hepatic fibrosis in inbred mice identifies the susceptibility locus Hfib1 on chromosome 15. | Q44231634 | ||
| Peroxisome proliferator-activated receptor-beta signaling contributes to enhanced proliferation of hepatic stellate cells. | Q44269271 | ||
| Angiogenesis-independent endothelial protection of liver: role of VEGFR-1. | Q44307079 | ||
| Human hepatic stellate cells express CCR5 and RANTES to induce proliferation and migration | Q44493296 | ||
| Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin | Q44729228 | ||
| Differential modulation of rat hepatic stellate phenotype by natural and synthetic retinoids | Q44749282 | ||
| Spontaneous recovery from micronodular cirrhosis: evidence for incomplete resolution associated with matrix cross-linking | Q44929886 | ||
| Immune stimulation of hepatic fibrogenesis by CD8 cells and attenuation by transgenic interleukin-10 from hepatocytes | Q45054700 | ||
| Noninvasive diagnosis of liver cirrhosis using DNA sequencer-based total serum protein glycomics | Q47580647 | ||
| A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis | Q47839389 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 98-105 | |
| P577 | publication date | 2004-12-01 | |
| P1433 | published in | Nature Reviews Gastroenterology & Hepatology | Q2108255 |
| P1476 | title | Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications | |
| P478 | volume | 1 |
| Q33773913 | A boswellic acid-containing extract ameliorates schistosomiasis liver granuloma and fibrosis through regulating NF-κB signaling in mice |
| Q48970633 | A novel strategy of profiling the mechanism of herbal medicines by combining network pharmacology with plasma concentration determination and affinity constant measurement. |
| Q45872572 | AAV vectors transduce hepatocytes in vivo as efficiently in cirrhotic as in healthy rat livers |
| Q37401935 | AMP-activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives. |
| Q45370699 | Accelerated liver fibrosis in hepatitis B virus transgenic mice: involvement of natural killer T cells |
| Q39010818 | Activated human hepatic stellate cells promote growth of human hepatocellular carcinoma in a subcutaneous xenograft nude mouse model |
| Q40039555 | Activated pericyte attenuates endothelial functions: nitric oxide-cGMP rescues activated pericyte-associated endothelial dysfunctions |
| Q35573111 | Adenosine inhibits cytosolic calcium signals and chemotaxis in hepatic stellate cells |
| Q46837274 | Adenosine monophosphate-activated protein kinase modulates the activated phenotype of hepatic stellate cells. |
| Q53025315 | Adiponectin modulates focal adhesion disassembly in activated hepatic stellate cells: implication for reversing hepatic fibrosis. |
| Q30478601 | Advanced MRI methods for assessment of chronic liver disease |
| Q37353099 | Advances in antifibrotic therapy |
| Q38932043 | Adverse outcome pathway development from protein alkylation to liver fibrosis |
| Q38936312 | Aging of the Liver: What This Means for Patients with HIV. |
| Q57246124 | Alterations in liver sinusoidal endothelium in a baboon model of type 1 diabetes |
| Q43297664 | Amelioration of hepatic fibrosis via Padma Hepaten is associated with altered natural killer T lymphocytes |
| Q28082569 | Angiogenesis and liver fibrosis |
| Q33830299 | Angiotensin-II-induced apoptosis requires regulation of nucleolin and Bcl-xL by SHP-2 in primary lung endothelial cells |
| Q45368591 | Anti-fibrotic effect of Cordyceps sinensis polysaccharide: Inhibiting HSC activation, TGF-β1/Smad signalling, MMPs and TIMPs |
| Q47188110 | Anti-fibrotic effects of Orostachys japonicus A. Berger (Crassulaceae) on hepatic stellate cells and thioacetamide-induced fibrosis in rats |
| Q50708999 | Anti-fibrotic effects of tetrandrine on bile-duct ligated rats. |
| Q53547058 | Antifibrotic activity of rofecoxib in vivo is associated with reduced portal hypertension in rats with carbon tetrachloride-induced liver injury. |
| Q36376477 | Antifibrotic agents for liver disease |
| Q57288769 | Antifibrotics in liver disease: are we getting closer to clinical use? |
| Q36382247 | Apoptosis and necrosis in the liver: a tale of two deaths? |
| Q33588960 | Association of interleukin-15-induced peripheral immune activation with hepatic stellate cell activation in persons coinfected with hepatitis C virus and HIV. |
| Q46407107 | Association of obestatin, ghrelin, and inflammatory cytokines in obese patients with non-alcoholic fatty liver disease. |
| Q28070358 | Astaxanthin as a Potential Protector of Liver Function: A Review |
| Q39154918 | Biochemical characterization and functional analysis of fructose-1,6-bisphosphatase from Clonorchis sinensis |
| Q36990696 | Biomarkers of hepatic fibrosis, fibrogenesis and genetic pre-disposition pending between fiction and reality |
| Q57805379 | Bone marrow derived-mesenchymal stem cells downregulate IL17A dependent IL6/STAT3 signaling pathway in CCl4-induced rat liver fibrosis |
| Q35803687 | Bone marrow-derived mesenchymal stem cells inhibit the proliferation of hepatic stellate cells by inhibiting the transforming growth factor β pathway |
| Q41603809 | CD151 supports VCAM-1-mediated lymphocyte adhesion to liver endothelium and is upregulated in chronic liver disease and hepatocellular carcinoma |
| Q64914810 | CD5L is a pleiotropic player in liver fibrosis controlling damage, fibrosis and immune cell content. |
| Q38347321 | Cannabidiol causes activated hepatic stellate cell death through a mechanism of endoplasmic reticulum stress-induced apoptosis |
| Q61456094 | Cannabinoids hurt, heal in cirrhosis |
| Q24648892 | Cellular and molecular mechanisms of fibrosis |
| Q39754535 | Changes in E-NTPDase 3 expression and extracellular nucleotide hydrolysis during the myofibroblast/lipocyte differentiation |
| Q43293089 | Changes in microRNAs associated with hepatic stellate cell activation status identify signaling pathways |
| Q37112309 | Chinese medicine CGA formula ameliorates DMN-induced liver fibrosis in rats via inhibiting MMP2/9, TIMP1/2 and the TGF-β/Smad signaling pathways |
| Q46756218 | Chronic ethanol intake promotes double gluthatione S-transferase/transforming growth factor-alpha-positive hepatocellular lesions in male Wistar rats |
| Q45402508 | Chronic inflammation associated with hepatitis C virus infection perturbs hepatic transforming growth factor beta signaling, promoting cirrhosis and hepatocellular carcinoma |
| Q38938744 | Clonorchis sinensis ferritin heavy chain triggers free radicals and mediates inflammation signaling in human hepatic stellate cells |
| Q50531945 | Close correlation of liver stiffness with collagen deposition and presence of myofibroblasts in non-alcoholic fatty liver disease. |
| Q41910979 | Combinatorial gene therapy renders increased survival in cirrhotic rats |
| Q35649473 | Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases |
| Q44042948 | Complement factor 5 is a quantitative trait gene that modifies liver fibrogenesis in mice and humans |
| Q28546937 | Computational chemical imaging for cardiovascular pathology: chemical microscopic imaging accurately determines cardiac transplant rejection |
| Q28478084 | Coordinated defects in hepatic long chain fatty acid metabolism and triglyceride accumulation contribute to insulin resistance in non-human primates |
| Q45953697 | Curcumin prevents liver fibrosis by inducing apoptosis and suppressing activation of hepatic stellate cells. |
| Q30473375 | Current status of novel antifibrotic therapies in patients with chronic liver disease |
| Q33954802 | Detection of novel biomarkers of liver cirrhosis by proteomic analysis |
| Q42339712 | Disease progression and liver cancer in the ferroportin disease. |
| Q54253472 | Down-regulation of microRNA-203-3p initiates type 2 pathology during schistosome infection via elevation of interleukin-33. |
| Q93148554 | Downregulation of miR-152 contributes to the progression of liver fibrosis via targeting Gli3 in vivo and in vitro |
| Q92840552 | Early laparoscopic cholecystectomy is associated with less risk of complications after the removal of common bile duct stones by endoscopic retrograde cholangiopancreatography |
| Q39572713 | Ecto-5'-nucleotidase/CD73 knockdown increases cell migration and mRNA level of collagen I in a hepatic stellate cell line |
| Q43120182 | Effect of aldosterone and its antagonist on the expression of PAI-1 and TGF-β1 in rat hepatic stellate cells |
| Q30887245 | Effect of curcumin on the proliferation and apoptosis of hepatic stellate cells |
| Q28568734 | Effect of phorbol ester and platelet-derived growth factor on protein kinase C in rat hepatic stellate cells |
| Q92616422 | Effects of Ethyl Pyruvate on Bile Duct Ligation-Induced Liver Fibrosis by Regulating Nrf2 Pathway and Proinflammatory Cytokines in Rats |
| Q40208528 | Effects of Ginkgo biloba extract on cell proliferation, cytokines and extracellular matrix of hepatic stellate cells |
| Q91720874 | Eosinophils and Macrophages within the Th2-Induced Granuloma: Balancing Killing and Healing in a Tight Space |
| Q82271227 | Evaluation of risk factors for the development of cirrhosis in autoimmune hepatitis: Japanese NHO-AIH prospective study |
| Q37768335 | Evolving challenges in hepatic fibrosis |
| Q49724206 | Exemestane Attenuates Hepatic Fibrosis in Rats by Inhibiting Activation of Hepatic Stellate Cells and Promoting the Secretion of Interleukin 10. |
| Q43103828 | Expression of angiotensinogen during hepatic fibrogenesis and its effect on hepatic stellate cells. |
| Q38185361 | Factor VII activating protease (FSAP): a novel protective factor in liver fibrosis |
| Q38047232 | Fibroblast autophagy in fibrotic disorders |
| Q34629775 | Fibronectin: functional character and role in alcoholic liver disease |
| Q64916752 | Fluorofenidone affects hepatic stellate cell activation in hepatic fibrosis by targeting the TGF-β1/Smad and MAPK signaling pathways. |
| Q36635544 | Flying under the radar: the immunobiology of hepatitis C. |
| Q51144849 | Fn14 hepatic progenitor cells are associated with liver fibrosis in biliary atresia. |
| Q34162432 | Focal Adhesion Assembly in Myofibroblasts Fosters a Microenvironment that Promotes Tumor Growth |
| Q34896641 | Fuzheng Huayu recipe alleviates hepatic fibrosis via inhibiting TNF-α induced hepatocyte apoptosis |
| Q36921638 | Gene modulation for treating liver fibrosis |
| Q26778035 | Genetic, metabolic and environmental factors involved in the development of liver cirrhosis in Mexico |
| Q92142600 | Gli3 is a novel downstream target of miR‑200a with an anti‑fibrotic role for progression of liver fibrosis in vivo and in vitro |
| Q55966751 | Glibenclamide protects against thioacetamide-induced hepatic damage in Wistar rat: investigation on NLRP3, MMP-2, and stellate cell activation |
| Q34142428 | Global analysis of DNA methylation in early-stage liver fibrosis |
| Q40244126 | Glycyrrhizic acid inhibits apoptosis and fibrosis in carbon-tetrachloride-induced rat liver injury |
| Q47939829 | Green tea infusion protects against alcoholic liver injury by attenuating inflammation and regulating the PI3K/Akt/eNOS pathway in C57BL/6 mice |
| Q38930049 | Hepatic Stellate Cells in Liver Fibrosis and siRNA-Based Therapy |
| Q54400567 | Hepatic expression profile of forkhead transcription factor genes in normal Balb/c mice and their dynamic changes after bile duct ligation. |
| Q41707214 | Hepatic fibrogenesis and transforming growth factor/Smad signaling activation in rats chronically exposed to low doses of lead |
| Q93140401 | Hepatic fibrosis: Avenues of investigation and clinical implications |
| Q42649234 | Hepatic stellate cells' involvement in progenitor-mediated liver regeneration |
| Q37869041 | Hepatic stellate cells: partners in crime for liver metastases? |
| Q41853921 | Hepatic tumor-stroma crosstalk guides epithelial to mesenchymal transition at the tumor edge |
| Q42581790 | Hepatic wound repair |
| Q36749431 | Hepatitis C virus infection--pathobiology and implications for new therapeutic options |
| Q36972087 | Hepatocyte polarity |
| Q37724707 | Hepatoprotective effect of Cichorium intybus L., a traditional Uighur medicine, against carbon tetrachloride-induced hepatic fibrosis in rats |
| Q51743206 | High regenerative capacity of the liver and irreversible injury of male reproductive system in carbon tetrachloride-induced liver fibrosis rat model. |
| Q64251219 | Histological and biochemical evaluation of transforming growth factor-β activation and its clinical significance in patients with chronic liver disease |
| Q45061974 | Human germline hedgehog pathway mutations predispose to fatty liver. |
| Q36540031 | Human hepatic stellate cells are resistant to apoptosis: implications for human fibrogenic liver disease |
| Q38552177 | Hypoxic hepatitis: a challenging diagnosis |
| Q90218089 | Identification of a Novel Deactivating Small-Molecule Compound for Fibrogenic Hepatic Stellate Cells |
| Q40211269 | Immunopathogenesis of hepatitis C virus infection and hepatic fibrosis: New insights into antifibrotic therapy in chronic hepatitis C. |
| Q35649461 | Infectious disease, the innate immune response, and fibrosis |
| Q39974242 | Inhibition of integrin alphavbeta6 on cholangiocytes blocks transforming growth factor-beta activation and retards biliary fibrosis progression |
| Q34193125 | Inhibitory effect of liposomal quercetin on acute hepatitis and hepatic fibrosis induced by concanavalin A |
| Q37672148 | Insulin-Like Growth Factor-1 Deficiency and Cirrhosis Establishment |
| Q38717345 | Interleukin-6 secreted by bipotential murine oval liver stem cells induces apoptosis of activated hepatic stellate cells by activating NF-κB-inducible nitric oxide synthase signaling |
| Q36661678 | Intermediate filament cytoskeleton of the liver in health and disease |
| Q92538659 | Interplay Between Macrophages and Angiogenesis: A Double-Edged Sword in Liver Disease |
| Q34992326 | Involvement of cholangiocyte proliferation in biliary fibrosis |
| Q36809625 | Is cirrhosis of the liver reversible? |
| Q37216420 | Keratin mutation predisposes to mouse liver fibrosis and unmasks differential effects of the carbon tetrachloride and thioacetamide models. |
| Q37612418 | Knockdown of histidine-rich calcium-binding protein (HRC) suppresses liver fibrosis by inhibiting the activation of hepatic stellate cells. |
| Q38957437 | K⁺-channel inhibition reduces portal perfusion pressure in fibrotic rats and fibrosis associated characteristics of hepatic stellate cells |
| Q39834604 | Lipid accumulation in hepatocytes induces fibrogenic activation of hepatic stellate cells |
| Q34010340 | Liver cirrhosis |
| Q87669646 | Liver fibrosis |
| Q51849650 | Liver fibrosis staging with contrast-enhanced ultrasonography: prospective multicenter study compared with METAVIR scoring. |
| Q80426407 | Liver fibrosis: from mechanisms to treatment |
| Q24645373 | Liver-specific beta-catenin knockout mice exhibit defective bile acid and cholesterol homeostasis and increased susceptibility to diet-induced steatohepatitis |
| Q40743488 | Mac the knife? Macrophages- the double-edged sword of hepatic fibrosis |
| Q33727374 | Macrophage-mediated phagocytosis of apoptotic cholangiocytes contributes to reversal of experimental biliary fibrosis. |
| Q26774649 | Macrophages During the Fibrotic Process: M2 as Friend and Foe |
| Q57492151 | Magnesium Isoglycyrrhizinate Ameliorates Fibrosis and Disrupts TGF-β-Mediated SMAD Pathway in Activated Hepatic Stellate Cell Line LX2 |
| Q90724782 | Mechanisms Underlying Hepatitis C Virus-Associated Hepatic Fibrosis |
| Q37865859 | Mechanisms of hepatic fibrogenesis |
| Q39586591 | Mechanisms of liver fibrosis associated with experimental Fasciola hepatica infection: roles of Fas2 proteinase and hepatic stellate cell activation. |
| Q42726347 | Melittin attenuates liver injury in thioacetamide-treated mice through modulating inflammation and fibrogenesis |
| Q28084572 | Membrane-to-Nucleus Signals and Epigenetic Mechanisms for Myofibroblastic Activation and Desmoplastic Stroma: Potential Therapeutic Targets for Liver Metastasis? |
| Q35061477 | Mesenchymal Stem Cells Pretreated with HGF and FGF4 Can Reduce Liver Fibrosis in Mice. |
| Q26796475 | Mesenchymal stromal cell therapy in liver disease: opportunities and lessons to be learnt? |
| Q34685429 | MicroRNA-130b promotes cell aggressiveness by inhibiting peroxisome proliferator-activated receptor gamma in human hepatocellular carcinoma |
| Q41642096 | MicroRNA-520g induces epithelial-mesenchymal transition and promotes metastasis of hepatocellular carcinoma by targeting SMAD7. |
| Q28303698 | Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets |
| Q43270510 | Modulation of extracellular matrix by nutritional hepatotrophic factors in thioacetamide-induced liver cirrhosis in the rat. |
| Q38032835 | Molecular serum markers of liver fibrosis. |
| Q80732285 | Morphologic features in the regenerating liver--a comparative intravital, lightmicroscopical and ultrastructural analysis with focus on hepatic stellate cells |
| Q94561518 | Myricetin Possesses Anthelmintic Activity and Attenuates Hepatic Fibrosis via Modulating TGFβ1 and Akt Signaling and Shifting Th1/Th2 Balance in Schistosoma japonicum-Infected Mice |
| Q34081750 | NDRG2 ameliorates hepatic fibrosis by inhibiting the TGF-β1/Smad pathway and altering the MMP2/TIMP2 ratio in rats |
| Q35808323 | NF-κB in the liver--linking injury, fibrosis and hepatocellular carcinoma |
| Q35097031 | Nanoscale hepatoprotective herbal decoction attenuates hepatic stellate cell activity and chloroform-induced liver damage in mice |
| Q40410801 | Neutralization of Interleukin-17 Attenuates Cholestatic Liver Fibrosis in Mice. |
| Q55429783 | Non-invasive in vivo Imaging Grading of Liver Fibrosis. |
| Q34017968 | Nrf2 pathway activation contributes to anti-fibrosis effects of ginsenoside Rg1 in a rat model of alcohol- and CCl4-induced hepatic fibrosis |
| Q33556420 | Nuclear beta-catenin induces an early liver progenitor phenotype in hepatocellular carcinoma and promotes tumor recurrence |
| Q89518894 | Obeticholic acid and INT-767 modulate collagen deposition in a NASH in vitro model |
| Q48114927 | Oleanolic Acid-amino Acids Derivatives: Design, Synthesis, and Hepatoprotective Evaluation In Vitro and In Vivo. |
| Q35256601 | Oral administration of Saccharomyces boulardii ameliorates carbon tetrachloride-induced liver fibrosis in rats via reducing intestinal permeability and modulating gut microbial composition |
| Q44270823 | Osteopontin delays resolution of liver fibrosis |
| Q37138768 | Oxidant stress-induced liver injury in vivo: role of apoptosis, oncotic necrosis, and c-Jun NH2-terminal kinase activation |
| Q37037061 | Oxidative and nitrosative stress and fibrogenic response |
| Q42558183 | Oxidative stress and antioxidants in hepatic pathogenesis |
| Q28075646 | Oxidative stress, a trigger of hepatitis C and B virus-induced liver carcinogenesis |
| Q28073856 | Pathobiology of wound healing after glaucoma filtration surgery |
| Q35547009 | Pathological aspects of bovine focal fibrogranulomatous proliferative panniculitis (Lechiguana). |
| Q91895459 | Pathological changes of liver one year later in CHB patients with negative HBV DNA |
| Q38800585 | Phenylethanol Glycosides from Cistanche tubulosa Suppress Hepatic Stellate Cell Activation and Block the Conduction of Signaling Pathways in TGF-β1/smad as Potential Anti-Hepatic Fibrosis Agents. |
| Q43598881 | Phosphorylated Smad2 and Smad3 signaling: Shifting between tumor suppression and fibro-carcinogenesis in chronic hepatitis C. |
| Q34406470 | Pro12Ala polymorphism of the peroxisome proliferator-activated receptor γ2 in patients with fatty liver diseases. |
| Q91832850 | Protein tyrosine phosphatase 1b deficiency protects against hepatic fibrosis by modulating nadph oxidases |
| Q35301810 | Proteomic analysis of mice fed methionine and choline deficient diet reveals marker proteins associated with steatohepatitis |
| Q33351256 | RACK1, a new ADAM12 interacting protein. Contribution to liver fibrogenesis |
| Q37121662 | Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. |
| Q24656684 | Redox mechanisms in hepatic chronic wound healing and fibrogenesis |
| Q45368415 | Relationship between the interleukin-28b gene polymorphism and the histological severity of hepatitis C virus-induced graft inflammation and the response to antiviral therapy after liver transplantation |
| Q30476541 | Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer |
| Q36382260 | Reversal of hepatic fibrosis -- fact or fantasy? |
| Q26771696 | Reversible Human TGF-β Signal Shifting between Tumor Suppression and Fibro-Carcinogenesis: Implications of Smad Phospho-Isoforms for Hepatic Epithelial-Mesenchymal Transitions |
| Q47812599 | Review article: the role of the microcirculation in liver cirrhosis |
| Q36693626 | Role of interleukin-1 and its antagonism of hepatic stellate cell proliferation and liver fibrosis in the Abcb4(-/-) mouse model. |
| Q26776555 | Role of redoximiRs in fibrogenesis |
| Q35834556 | Significance of increased expression of decoy receptor 3 in chronic liver disease |
| Q38827092 | Sinusoidal communication in liver fibrosis and regeneration. |
| Q45872599 | Soluble CD146, a novel endothelial marker, is related to the severity of liver disease |
| Q39238185 | Stage-specific expression, immunolocalization of Clonorchis sinensis lysophospholipase and its potential role in hepatic fibrosis |
| Q40227030 | Study on effects of extracts from Salvia Miltiorrhiza and Curcuma Longa in inhibiting phosphorylated extracellular signal regulated kinase expression in rat's hepatic stellate cells |
| Q41756299 | Succinate is a paracrine signal for liver damage |
| Q38884278 | Suppressive effect of SATB1 on hepatic stellate cell activation and liver fibrosis in rats |
| Q33868614 | Synergistic effect of a novel oxymatrine-baicalin combination against hepatitis B virus replication, alpha smooth muscle actin expression and type I collagen synthesis in vitro |
| Q36737131 | TGF-β/SMAD Pathway and Its Regulation in Hepatic Fibrosis |
| Q34120419 | TGF-β/Smad signaling during hepatic fibro-carcinogenesis (review). |
| Q51065073 | TGF-β1-induced synthesis of collagen fibers in skeletal muscle-derived stem cells. |
| Q34486752 | TPX2 is a prognostic marker and contributes to growth and metastasis of human hepatocellular carcinoma |
| Q37587875 | Targeting liver fibrosis: strategies for development and validation of antifibrotic therapies. |
| Q36904042 | The CYP2E1 inhibitor DDC up-regulates MMP-1 expression in hepatic stellate cells via an ERK1/2- and Akt-dependent mechanism |
| Q64087497 | The Role of Pathological Aging in Cardiac and Pulmonary Fibrosis |
| Q36663411 | The anti-fibrotic effect of bone morphogenic protein-7(BMP-7) on liver fibrosis |
| Q39986543 | The hepatitis B virus X protein induces paracrine activation of human hepatic stellate cells |
| Q38955273 | The interplay between apoptosis, mitophagy and mitochondrial biogenesis induced by resveratrol can determine activated hepatic stellate cells death or survival |
| Q39290360 | The murine lens: A model to investigate in vivo epithelial-mesenchymal transition |
| Q57040481 | The potential effects of silver and gold nanoparticles as molluscicides and cercaricides on Schistosoma mansoni |
| Q38637342 | The protective effect of bee venom on fibrosis causing inflammatory diseases |
| Q38336979 | The rno-miR-34 family is upregulated and targets ACSL1 in dimethylnitrosamine-induced hepatic fibrosis in rats |
| Q47243685 | The soluble guanylate cyclase stimulator IW-1973 prevents inflammation and fibrosis in experimental non-alcoholic steatohepatitis |
| Q34401307 | The therapeutic effects of tectorigenin on chemically induced liver fibrosis in rats and an associated metabonomic investigation. |
| Q26829662 | Therapeutic potential of microRNA: a new target to treat intrahepatic portal hypertension? |
| Q46247560 | Thio-barbiturate-derived compounds are novel antioxidants to prevent LPS-induced inflammation in the liver |
| Q46554515 | Thymoquinone alleviates nonalcoholic fatty liver disease in rats via suppression of oxidative stress, inflammation, apoptosis |
| Q54320620 | Towards treatment of viral pathogenesis. |
| Q36588242 | Transcriptional regulation of stellate cell activation |
| Q92661465 | Tumor-Stroma Crosstalk Enhances REG3A Expressions that Drive the Progression of Hepatocellular Carcinoma |
| Q34224706 | Ultrastructure of oval cells in children with chronic hepatitis B, with special emphasis on the stage of liver fibrosis: the first pediatric study |
| Q33443530 | Up-regulation of uPARAP/Endo180 during culture activation of rat hepatic stellate cells and its presence in hepatic stellate cell lines from different species |
| Q42011268 | Vasodilator-stimulated phosphoprotein promotes activation of hepatic stellate cells by regulating Rab11-dependent plasma membrane targeting of transforming growth factor beta receptors |
| Q51998552 | Wnt'er in liver: expression of Wnt and frizzled genes in mouse. |
| Q43189041 | Xanthohumol, a chalcon derived from hops, inhibits hepatic inflammation and fibrosis |
| Q42984311 | YKL-40-gene polymorphism affects acute cellular rejection and fibrosis progression after transplantation for hepatitis C virus-induced liver disease |
| Q90150816 | Zeaxanthin Dipalmitate in the Treatment of Liver Disease |
| Q92523630 | hUCMSC-extracellular vesicles downregulated hepatic stellate cell activation and reduced liver injury in S. japonicum-infected mice |
Search more.